However, our investigations using in vitro hyperglycaemic conditions and monocytes and endothelial cells from T2DM patients did not reveal any differences in the expression pattern of SGLT-2, indicating that diabetes conditions do not stimulate SGLT-2 expression in these cells. This evidence concerns the gene SLC5A2 and type 2 diabetes mellitus.